Skip to main content
Loading

Adapting analytics and quality control to ensure adequate safety, purity, and potency of final products

15 Apr 2025
C & G Manufacturing
  • What are the most important critical quality attributes (CQAs) for gene therapy products?
  • Should the potency assays include both expression and functional aspects?  Why?
  • What is the role of infectivity assay in the quality control of gene therapy products?  Could it ever be made more robust?
  • Does structure-function studies have a role to play for product characterization for gene therapy products?
  • What are the considerations in proposing limits of DNA impurities in gene therapy products?
Industry Expert
Sudhir Burman, Senior Director, Analytical Science & Technology - Gemma BioTherapeutics